Amid the rising numbers of Coronavirus cases in India, their is a good news. Drug firm Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 patients. Watch this video for more details.
